EuBiologics Co.,Ltd. is an enterprise located in South Korea, with the main office in Seoul. The enterprise operates in the Biological Product (except Diagnostic) Manufacturing industry. EuBiologics Co.,Ltd. was incorporated on March 10, 2010. EuBiologics Co.,Ltd. currently employs 335 (2024) people. The latest financial highlights indicate a net sales revenue increase of 97.37% in Q3C2025. During that time, EuBiologics Co.,Ltd.’s total assets grew by 32.63%. In, 2025, the company’s net profit margin increased by 16.78%.

Headquarters
8F, Seongdo Bldg., 207, Dosan-Daero, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the EuBiologics Co.,Ltd. report to view the information.

Website: http://www.eubiologics.com

Basic Information

Total Employees:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Outstanding Shares:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Registered Capital:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Financial Auditors:

Purchase the EuBiologics Co.,Ltd. report to view the information.

Incorporation Date:

March 10, 2010

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

9.9%

Purchase this report to view the information.

8.4%

Purchase this report to view the information.

6.3%

Subsidiaries

(주)벡스퍼트

Company Performance

Financial values in the chart are available after EuBiologics Co.,Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

97.37%▲

Total Operating Revenue

98.27%▲

Operating Profit

151.3%▲

EBITDA

121.24%▲

Net Profit/Loss for the Period

279.61%▲

Total Assets

32.63%▲

Total Equity

40.19%▲

Operating Profit Margin

7.83%▲

Net Profit Margin

16.78%▲

Return on Equity (ROE)

14.83%▲

Quick Ratio

1.36%▲

Cash Ratio

0.32%▲

EuBiologics Co.,Ltd. (South Korea)